Zurueck zur Suche

Reporte zur Charge UT8137BA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 2 RI 1 MN 1 NY 1

VAERS 2689657

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8137BA

mild
Staat
RI
Alter
80,0
Geschlecht
F
Eingang
02.10.2023
Impfdatum
29.09.2023
Beginn
30.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Erythema Peripheral swelling Skin warm

Symptomtext

24 hours after receiving vaccine, the patient describes severe chill, a large red bump with a width of 3-inch bump in her arm, and it is warm to the touch. The patient presented to the pharmacy 3 days after vaccination. The patient arm was no longer swollen but remains red and warm to the touch. I recommended the patient take Benadryl at bedtime to help with the reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A Patient does not fill at said location
Allergien
No allergies noted in system or patient profile.
Vorherige Impfungen
-

VAERS 2725891

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8137BA

gering
Staat
MN
Alter
60,0
Geschlecht
M
Eingang
20.12.2023
Impfdatum
20.12.2023
Beginn
20.12.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

No harm to patient, pt received high dose flu vaccine and is not over 65 years of age

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
n/a
Vorgeschichte
hep c, copd, htn, dm2, bronchiectasis
Andere Medikamente
gabapentin, tylenol, albuterol, arformoterol, budesonide, cholecalcif, diltiazem, famotidine, losartan, mantelukast, ipatropium bromide, revfenacin, trazadone
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2715883

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8137BA

gering
Staat
VA
Alter
65,0
Geschlecht
F
Eingang
20.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Low temperature reached: NEGATIVE 3.7? C / 1 HOUR AND 46 MINUTES she administered the Fluzone Hd Qiv to multiple patients with no reported adverse event; Initial information received on 08-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 65 years old female patient and reporter reported temperature excursion for Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent]/ low temperature reached: negative 3.7? c / 1 hour and 46 minutes she administered the fluzone hd qiv to multiple patients with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Quadrival A-B High Dose Hv Vaccine (lot number: UT8137BA) (Expiry date: 30-Jun-2024) (with an unknown strength, formulation) via unknown route in unknown administration site for prophylactic vaccination (Immunisation). On an unknown date, the reporter reported temperature excursion for Influenza Quadrival A-B High Dose Hv Vaccine/low temperature reached: negative 3.7? c / 1 hour and 46 minutes she administered the fluzone hd qiv to multiple patients with no reported adverse event (poor quality product administered) (latency: same day). It was reported, Caller provided inquiry number and she said she was advised that the vaccines was not suitable for use anymore. Caller was asking if we have any information on using ADACEL, FLUZONE QIV T, AND FLUZONE HD QIV after she was advised not to use it because of an excursion. Caller stated that she administered the Fluzone Qiv T And Fluzone Hd Qiv to multiple patients, but she only provided 1 patient for each vaccine, because she said it will take a lot of time if she would track all the product and patient information, and she stated that she only wants to know if we have any information on using ADACEL, FLUZONE QIV T, AND FLUZONE HD QIV after she was advised not to use it because of an excursion. Caller was in a hurry. This situation is reported to PV as medication errors due to the possible inappropriate administration of these products after the excursion occurred that were not supported by the extended stability information post excursion. Reason: Fridge malfunction Low temperature reached: NEGATIVE 3.7? C Duration out of labelled range: 1 HOUR AND 46 MINUTES If negative advice, have products been administered post excursion: YES, FLUZONE HD QIV WAS PUNCTURED AFTER EXCURSION Does extended stability data cover the excursion! NO Human Error! NO This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA353747:01836321, 01836324 US-SA-2023SA353804:01835076, 01836277, 01836324

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2698219

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8137BA

gering
Staat
VA
Alter
75,0
Geschlecht
F
Eingang
18.10.2023
Impfdatum
09.10.2023
Beginn
11.10.2023
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Blister Erythema Hypersensitivity Peripheral swelling

Symptomtext

Pt received vaccines on 10/9, got IV contrast dye on 10/10, then called 10/11 to say that her right arm was red and swollen and also both thighs were red and swollen. She went to the hospital on 10/14 because her legs became blistered and was treated for an allergic reaction. The hospital was not able to determine the cause of the reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blister
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2697172

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8137ba

gering
Staat
NY
Alter
75,0
Geschlecht
F
Eingang
17.10.2023
Impfdatum
17.10.2023
Beginn
17.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Peripheral swelling

Symptomtext

Patient reported fingers started to swell about 5- 10 minutes after receiving vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Peripheral swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
gout
Vorgeschichte
asthma, arthritis, obesity
Andere Medikamente
allopurinol, colchicine, dorzolamide, matzim, prednisone, valsartan/hctz
Allergien
shellfish
Vorherige Impfungen
-